It’s true that we’ve already checked off the moon, cracked the human genome, and invented a car that drives itself—but still, in front of a new wrinkle in the mirror, we all collapse like 12th graders before a math final. In the 21st century, we have Waze for almost everything—except the way back to the skin of a 20-year-old. For that, we have hyaluronic acid, that tiny molecule that gives us all FOMO because it knows what we all want: To retain water like a camel in the desert and make the skin look as if we’ve slept eight hours instead of three.
Our encounters with it used to happen only by appointment, next to a doctor, with sterile gloves and a reassuring gaze that said, “Don’t worry, it won’t hurt at all.” We wanted a little flexibility in the skin—and got a shot every time. We wanted radiance—and got a conversation about volumes, filling, and rejuvenation.
But even within the world of hyaluronic acid, there is a clear hierarchy. On one hand, there is regular, non-crosslinked hyaluronic acid—a molecule that the skin absorbs easily, providing immediate hydration and a fresh look, but that breaks down quickly, so its effect is relatively short-lived. On the other hand, there is crosslinked hyaluronic acid, known from medical injections, with its stable three-dimensional structure that remains in the skin much longer and stimulates collagen production. Until now, anyone who wanted to enjoy this advantage had to book an injection—befriend the syringe and trust the person holding it close to their face. But now, science has opened a window and told us it’s possible without pain, without redness, and without prayers before, during, and after—while everyone will see the difference.
Hava Zingboim’s skin-tech brand has launched PROPHECY NEW, the fantasy of anyone who fears needles and bank managers. What was possible until now only via injection is now also possible through creams or serums available on the shelf. The secret lies in the technology—which has received PATENT PENDING status for its original and unique development—allowing, for the first time, the penetration of miniaturized crosslinked hyaluronic acid through topical application while preserving its three-dimensional structure over time. These are the only products containing miniaturized crosslinked hyaluronic acid, showing in studies a rejuvenation of the biological age of facial skin by about two and a half years—in just two weeks. A dream.
Behind the development is Hava Zingboim’s scientific team, which, after persistent work, succeeded in miniaturizing the crosslinked hyaluronic acid molecule without breaking its crosslinked structure. This created a penetrative and stable molecule in topical application, capable of triggering a biostimulatory response of autonomous collagen renewal deep in the skin.
Zingboim is not satisfied with just making the skin softer for a day. The approach here is biological, not cosmetic. Instead of treating the symptom—that is, the wrinkles already formed—the formulas work on two deep levels: At the epidermal level, they strengthen the barrier, soothe, and provide immediate hydration. But the real work begins at the dermal level, where they build water reserves, stimulate collagen production, and restore the skin’s architecture. And you already understand what this combination does to your skin and remember how much it can rejuvenate it, right?
In the new line, three heroes await to make a difference for your skin: A light gel-cream for building moisture reserves and improving texture with a pleasant feel; a rich cream that tackles the mission when it senses dry, mature skin craving more emotional support and flexibility; and a biostimulatory serum to restore the epidermal barrier, reduce inflammation, and encourage cellular renewal. All are effective, all know their craft, and all are based on miniaturized crosslinked hyaluronic acid.
“Miniaturizing hyaluronic acid and the ability to penetrate it deep into the skin through topical application used to seem like a fantasy, and today it is a scientific fact. Years later, we succeeded in also miniaturizing crosslinked hyaluronic acid—for the first time and exclusively in the world,” Hava Zingboim concludes about the breakthrough achieved with the new line. And us? We are still trying to process this revolutionary invention. Because who would have believed that the way to younger-looking skin would pass through a jar on the shelf, not a needle in a clinic? For years we feared the syringe, and today the only thing stressing us out is that the cream will run out too soon. After all, the cost is NIS 595–695 per product.